GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: MRL-367 is a selective, small molecule antagonist of RORγt, an isoform of RORγ (RAR related orphan receptor C), with antiinflammatory potential [1].
|
|
|||||||||||||||||||||||||||||||||||
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References |
| Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Experimental compound with predicted application in RA. | |
| Inflammatory bowel disease |
Disease Ontology:
DOID:0050589 OMIM: 266600 |
Experimental compound with predicted application in inflammatory bowel disease. | |
| Psoriatic arthritis |
Disease Ontology:
DOID:9008 |
Experimental compound with predicted application in PsA. | |
| Ankylosing spondylitis |
Disease Ontology:
DOID:7147 |
Experimental compound with predicted application in ankylosing spondylitis. | |